Accelerating Drug Discovery With High-Throughput Crystallographic Fragment Screening and Structural Enablement

被引:0
|
作者
Fearon, Daren [1 ,2 ]
Powell, Ailsa [1 ,2 ]
Douangamath, Alice [1 ,2 ]
Dias, Alexandre [1 ,2 ]
Tomlinson, Charles W. E. [1 ,2 ]
Balcomb, Blake H. [1 ,2 ]
Aschenbrenner, Jasmin C. [1 ,2 ]
Aimon, Anthony [1 ,2 ]
Barker, Isabel A. [1 ,2 ]
Brandão-Neto, José [1 ,2 ]
Collins, Patrick [1 ,2 ]
Dunnett, Louise E. [1 ,2 ]
Fairhead, Michael [3 ]
Gildea, Richard J. [1 ]
Golding, Mathew [1 ,2 ]
Gorrie-Stone, Tyler [1 ,2 ]
Hathaway, Paul V. [1 ]
Koekemoer, Lizbé [3 ]
Krojer, Tobias [3 ]
Lithgo, Ryan M. [1 ,2 ]
Maclean, Elizabeth M. [3 ]
Marples, Peter G. [1 ,2 ]
Ni, Xiaomin [3 ]
Skyner, Rachael [1 ,2 ]
Talon, Romain [1 ,2 ]
Thompson, Warren [1 ,2 ]
Wild, Conor F. [1 ,2 ]
Winokan, Max [1 ,2 ]
Wright, Nathan David [3 ]
Winter, Graeme [1 ]
Shotton, Elizabeth J. [1 ]
von Delft, Frank [1 ,2 ,3 ,4 ]
机构
[1] Diamond Light Source Ltd, Harwell Science and Innovation Campus, Oxfordshire, Didcot, United Kingdom
[2] Research Complex at Harwell, Harwell Science and Innovation Campus, Oxfordshire, Didcot, United Kingdom
[3] Centre for Medicines Discovery, University of Oxford, NDM Research Building, Oxfordshire, Oxford, United Kingdom
[4] Department of Biochemistry, University of Johannesburg, Johannesburg, South Africa
来源
Applied Research | 2025年 / 4卷 / 01期
关键词
Drug discovery;
D O I
10.1002/appl.202400192
中图分类号
学科分类号
摘要
Fragment-based drug discovery is a well-established method for the identification of chemical starting points for development into clinical candidates. Historically, crystallographic fragment screening was perceived to be low-throughput and time consuming. However, thanks to advances in synchrotron capabilities and the introduction of dedicated facilities, such as the XChem platform at Diamond Light Source, there have been substantial improvements in throughput and integration between sample preparation, data collection and hit identification. Herein we share our experiences of establishing a crystallographic fragment screening facility, our learnings from operating a user programme for ten years and our perspective on applying structural enablement to rapidly progress initial fragment hits to lead-like molecules. © 2024 The Author(s). Applied Research published by Wiley-VCH GmbH.
引用
收藏
相关论文
共 50 条
  • [1] High-Throughput crystallographic fragment screening for drug discovery
    Metz, Alexander
    Huschinann, Franziska
    Schiebel, Johannes
    Mueller, Utiye
    Weiss, Manfred
    Heine, Andreas
    Melte, Gerhard
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2018, 74 : E24 - E24
  • [2] High-throughput screening for drug discovery
    Broach, JR
    Thorner, J
    NATURE, 1996, 384 (6604) : 14 - 16
  • [3] Accelerating enzyme discovery and engineering with high-throughput screening
    Bozkurt, Eray U.
    Orsted, Emil C.
    Volke, Daniel C.
    Nikel, Pablo I.
    NATURAL PRODUCT REPORTS, 2024,
  • [4] Accelerating Discovery and Development with Advances in High-Throughput Screening
    Challener, Cynthia A.
    Pharmaceutical Technology, 2024, 48 (11) : 12 - 16
  • [5] Accelerating drug discovery by high-throughput combinatorial synthesis
    Banville, SC
    Zuckermann, RN
    PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON LABORATORY AUTOMATION AND ROBOTICS 1996, 1997, : 77 - 92
  • [6] High-throughput screening, metabolomics and drug discovery
    Harrigan, GG
    Yates, LA
    IDRUGS, 2006, 9 (03) : 188 - 192
  • [7] Accelerating Electrolyte Discovery for Energy Storage with High-Throughput Screening
    Cheng, Lei
    Assary, Rajeev S.
    Qu, Xiaohui
    Jain, Anubhav
    Ong, Shyue Ping
    Rajput, Nay Nidhi
    Persson, Kristin
    Curtiss, Larry A.
    JOURNAL OF PHYSICAL CHEMISTRY LETTERS, 2015, 6 (02): : 283 - 291
  • [8] High-throughput screening in combinatorial chemistry for drug discovery
    Krstulovic, AM
    JOURNAL OF CHROMATOGRAPHY B, 1999, 725 (01): : 1 - 1
  • [9] High-throughput virtual screening for drug discovery in parallel
    Toledo-Sherman, LM
    Chen, DQ
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 414 - 421
  • [10] High-throughput screening approaches to TB drug discovery
    Stanley, Sarah A.
    Grant, Sarah S.
    Barczak, Amy K.
    Hung, Deborah T.
    TUBERCULOSIS, 2013, 93 (01) : 110 - 110